Literature DB >> 9894885

Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury.

G S Scott1, L B Jakeman, B T Stokes, C Szabó.   

Abstract

Peroxynitrite formation and the subsequent activation of the nuclear enzyme, poly (adenosine diphosphate [ADP]-ribose) synthetase (PARS), has been implicated in the pathogenesis of several neurodegenerative disorders. Here, we demonstrate that nitrotyrosine, an indicator of peroxynitrite generation, and poly (ADP) ribose, a marker of PARS activation, were selectively localized within tissues from spinal cord-injured rats. Our data implicate a role for peroxynitrite production and PARS activation in the development of spinal cord trauma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9894885

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

Review 1.  Ischemic injury and faulty gene transcripts in the brain.

Authors:  P K Liu; R G Grossman; C Y Hsu; C S Robertson
Journal:  Trends Neurosci       Date:  2001-10       Impact factor: 13.837

Review 2.  Transcripts of damaged genes in the brain during cerebral oxidative stress.

Authors:  Philip K Liu; Tarun Arora
Journal:  J Neurosci Res       Date:  2002-12-15       Impact factor: 4.164

3.  Kainate-mediated excitotoxicity induces neuronal death in the rat spinal cord in vitro via a PARP-1 dependent cell death pathway (Parthanatos).

Authors:  Anujaianthi Kuzhandaivel; Andrea Nistri; Miranda Mladinic
Journal:  Cell Mol Neurobiol       Date:  2010-05-26       Impact factor: 5.046

4.  Stability, disposition, and penetration of catalytic antioxidants Mn-porphyrin and Mn-salen and of methylprednisolone in spinal cord injury.

Authors:  Liqin Wu; Yichu Shan; Danxia Liu
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-06

Review 5.  Antioxidant therapies for acute spinal cord injury.

Authors:  Edward D Hall
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

6.  Uric acid protects against secondary damage after spinal cord injury.

Authors:  Gwen S Scott; Salvatore Cuzzocrea; Tiziana Genovese; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

7.  NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase.

Authors:  A S Mandir; M F Poitras; A R Berliner; W J Herring; D B Guastella; A Feldman; G G Poirier; Z Q Wang; T M Dawson; V L Dawson
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

8.  Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase.

Authors:  L Liaudet; F G Soriano; E Szabó; L Virág; J G Mabley; A L Salzman; C Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 9.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

10.  Transforming growth factor-beta1 regulates the fate of cultured spinal cord-derived neural progenitor cells.

Authors:  S M Park; J S Jung; M S Jang; K S Kang; S K Kang
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.